Dennis Slamon, MD, PhD, discusses HER2 and the development of Herceptin.
Dennis Slamon, MD, PhD
Advertisement
Articles by Dennis Slamon, MD, PhD
Advertisement
Latest Updated Articles
- In the Beginning
Published: June 8th 2009 | Updated:
Advertisement
Advertisement
Trending on CURE
1
HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT
2
Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer
3
Presurgical Enhertu Combo Elicits Response Benefit in HER2+ Early Breast Cancer
4
Tiragolumab Plus Tecentriq Doesn’t Improve NSCLC Outcomes
5
